Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock (ACRV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACRV · as of Jun 8, 2026
Key Statistics
Explore Acrivon Therapeutics, Inc. Common Stock Data
acrv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 90.0%
The ACRV analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $21.83, representing +1448.23% upside from the current price of $1.41.
Competitors & Peers
acrv competitorsACRV
ATYR
BMEA
CBUS
IMUX
PMVPStock Performance
Full HistoryAbout Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumor…
what is acrivon therapeutics, inc. common stock · acrv stock overview · acrivon therapeutics, inc. common stock company profile · who is acrivon therapeutics, inc. common stock ceo · acrv NASDAQ · acrivon therapeutics, inc. common stock headquarters · acrivon therapeutics, inc. common stock business segments
About Stock Overview & Key Data
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 15, 2022. As of the latest trading session, ACRV stock price is $1.41, with a market capitalization of $44.5M. The stock has returned +10.16% over the past 12 months and -41.49% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Acrivon Therapeutics, Inc. Common Stock stock is Buy, with an average 12-month price target of $21.83. In fiscal year 2025, Acrivon Therapeutics, Inc. Common Stock reported revenue of — and net income of -$77.9M. For detailed data — including Acrivon Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Acrivon Therapeutics, Inc. Common Stock (ACRV) stock price is $1.41. The stock is traded on NASDAQ under the ticker symbol ACRV. The 52-week range is $1.15 – $3.56.